FDA Clearance Tracker · K182004
PENTAX Medical Endoscopic Ultrasound System
Last checked: Nov 19, 2026Latest source record: Aug 21, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Aug 21, 2018
Substantially Equivalent
Time to decision
25 days
Received Jul 27, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K182004
- Device name
- PENTAX Medical Endoscopic Ultrasound System
- Applicant
- Pentax of America, Inc.
- Applicant location
- Montvale, NJ
- Received
- Jul 27, 2018
- Decided
- Aug 21, 2018
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.1500
- Specialty
- GI, Urology & NephrologyUrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- We could not check whether this was the first decision under its product code.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K182004
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Pentax of America, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.